Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

353
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
353
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

885
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
885
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Hypodermis01:02

Hypodermis

3.9K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
3.9K
Lethal Alleles02:41

Lethal Alleles

13.9K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nicotinic acetylcholine receptors and their role in ghrelin-producing cells.

Biochemical and biophysical research communications·2026
Same author

A case of type 2 diabetes with spinal and bulbar muscular atrophy treated with oral semaglutide while sparing muscle reduction for two years: a case report with literature review.

Diabetology international·2026
Same author

Establishment of a low dose rate 133Ba γ-ray calibration field for photon energy in the 300-400 keV range.

Radiation protection dosimetry·2026
Same author

Immune tolerance induction using the thyrotropin receptor epitope 78-94 (p37) prevents Graves' disease in HLA-DR3 transgenic mice.

Frontiers in immunology·2025
Same author

Conversion coefficients and air density correction factors for new operational quantities in monoenergetic photon calibration fields.

Journal of radiological protection : official journal of the Society for Radiological Protection·2025
Same author

Identification of the right adrenal vein opening using intraoperative 4D-CT angiography from the right adrenal artery in adrenal vein sampling: A case report.

Radiology case reports·2025

Related Experiment Video

Updated: May 20, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

228

Severe obesity with hypo-leptinemia.

Masanori Kita1, Shuhei Morita1, Hiroyuki Ariyasu2

  • 1First Department of Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.

Endocrine Journal
|March 25, 2025
PubMed
Summary

Hypo-leptinemia, a condition of low leptin, is linked to obesity and increased appetite. In severe obesity cases, leptin replacement therapy may be considered even without genetic abnormalities.

Keywords:
HypopituitarismHypothalamic disordersLeptinObesity

More Related Videos

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

5.9K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.9K

Related Experiment Videos

Last Updated: May 20, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

228
Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

5.9K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

6.9K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Obesity Research

Background:

  • Obesity is sometimes associated with hypo-leptinemia, potentially leading to increased appetite and weight gain.
  • Leptin replacement therapy is a theoretical treatment for hypo-leptinemia-related obesity, but requires further case studies.

Purpose of the Study:

  • To investigate serum leptin levels and their correlation with body mass index (BMI) in 107 obese patients.
  • To identify individuals with hypo-leptinemia and analyze a specific case of congenital hypopituitarism with severe obesity.

Main Methods:

  • Serum leptin levels and BMI were measured in 107 obese patients.
  • A detailed clinical and pathological investigation was conducted on one patient with congenital hypopituitarism, including genetic analysis and electron microscopy of adipose tissue.

Main Results:

  • One patient with congenital hypopituitarism presented with severe obesity (BMI 41.5 kg/m²), central hypogonadism, diabetes insipidus, growth hormone deficiency, cognitive impairment, and abnormal eating behavior.
  • Genetic analysis showed no mutations in leptin-related genes. Subcutaneous adipose tissue revealed relatively smaller adipocytes compared to a BMI-matched control.
  • The patient experienced progressive health issues, including dialysis and eventual death from pneumonia.

Conclusions:

  • Severe obesity with hypo-leptinemia may involve disturbances in adipocyte expansion due to unknown dysfunctions.
  • Leptin-replacement therapy could be considered for severely obese patients with hypo-leptinemia, even in the absence of identified abnormalities in leptin-related genes.